INS and type 2 diabetes mellitus: Although the prevalence of insulin monotherapy among patients with type 2 diabetes in Bangladesh accounts for less than 7.3% to 14.0% [47, 48], additional research is needed to provide evidence-based guidelines for long-term diabetes patients in Bangladesh to keep control of the periodontal disease.